Based on immunohistochemistry assay results, Noske et al found that Akt expression was 58% higher in primary ovarian carcinoma compared with that in NOTs, and it was significantly associated with positive lymph node rates and International Federation of Gynecology and Obstetrics stages (15). This evidence concerns the gene AKT1 and ovarian carcinoma.